文献速递生殖医学

使用市售解冻液对玻璃化人囊胚进行一步法复苏技术

One-step warming technique for vitrified human blastocysts using commercially available thawing solutions.
PubMed 文献 · Reprod Biomed Online · 2025-07-23

本回顾性队列研究纳入2022年12月至2024年12月间1173例FET,比较一步法与多步法复苏玻璃化囊胚的复张率和临床结局。一步法复苏后4-5小时复张率(92.4%)显著高于多步法(86.8%)(P=0.0009),临床妊娠率也显著更高(69.3% vs 61.2%,P=0.0042),但持续妊娠率无显著差异。三种市售解冻液品牌间无显著差异。

要点

  • 一步法复苏后复张率92.4%,显著高于多步法86.8%(P=0.0009)。
  • 一步法临床妊娠率69.3%,显著高于多步法61.2%(P=0.0042)。
  • 持续妊娠率一步法53.9% vs 多步法49.2%,无显著差异。

核心结论

  • 一步法复苏的复张和临床结局优于多步法,且三种市售解冻液品牌效果相当。

研究设计与样本

  • 回顾性队列研究,纳入2022年12月至2024年12月期间年龄<42岁的1173例冻胚移植(FET)。
  • 囊胚按多步法复苏指南(使用Reprolife溶液)或一步法复苏(在解冻液中浸泡1分钟)进行。
  • 复苏后囊胚在恢复培养基中培养2-3小时,然后转移至胚胎移植培养基,再2小时后进行胚胎移植。
  • 比较573例一步法FET与600例多步法FET,以及一步法中使用三种不同品牌解冻液的亚组:Irvine(319例FET)、Kitazato(128例FET)和Reprolife(126例FET)。

主要发现

  • 一步法复苏后4-5小时复张率为92.4%,多步法为86.8%,差异显著(P=0.0009)。
  • 一步法临床妊娠率为69.3%,多步法为61.2%,差异显著(P=0.0042)。
  • 一步法持续妊娠率为53.9%,多步法为49.2%,无显著差异。
  • 三种不同品牌解冻液用于一步法复苏时,复张率或临床结局均无显著差异。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RESEARCH QUESTION: What are the re-expansion rates and clinical outcomes obtained when employing a one-step warming technique using three commercially available thawing solutions on vitrified blastocysts, and how do they compare with the standard multi-step warming technique? DESIGN: This retrospective cohort study involved 1173 frozen embryo transfers (FET) in women aged <42 years between December 2022 and December 2024. The blastocysts were warmed following multi-step warming guidelines (with Reprolife solutions) or using one-step warming with 1 min of immersion in a thawing solution. Warmed blastocysts were cultured in a recovery medium for 2-3 h, and then transferred to the embryo transfer medium. Embryo transfer was performed after another 2 h. Survival, re-expansion and clinical outcomes were compared between 573 FET using one-step warming and 600 FET using multi-step warming, as well as between one-step warming using three different brands of thawing solution: Irvine (319 FET), Kitazato (128 FET) and Reprolife (126 FET). RESULTS: The re-expansion rate of blastocysts after 4-5 h was significantly higher with one-step warming (92.4%) compared with multi-step warming (86.8%) (P = 0.0009). The clinical pregnancy rate was also significantly higher with one-step warming (69.3%) compared with multi-step warming (61.2%) (P = 0.0042), but the ongoing pregnancy rate did not differ significantly between one-step warming (53.9%) and multi-step warming (49.2%). No significant differences in re-expansion or clinical outcomes were detected between the three different brands of thawing solution used for one-step warming. CONCLUSIONS: One-step warming results in better re-expansion and clinical outcomes than multi-step warming, and one-step warming is equally effective with the three commercially available brands of thawing solution tested.

来源:Reprod Biomed Online,查看原文。版权归原作者所有。

引用

  1. Kato R, Itoi F, Tajima A, et al. One-step warming technique for vitrified human blastocysts using commercially available thawing solutions. Reprod Biomed Online. 2025. PMID: 41289879. doi:10.1016/j.rbmo.2025.105168

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。